# AZD1152 in Patients With Advanced Solid Malignancies-Study 3

> **NCT00497679** · PHASE1 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 45 (estimated)

## Conditions studied

- Solid Tumours

## Interventions

- **DRUG:** AZD1152

## Key facts

- **NCT ID:** NCT00497679
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-08
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 45 (ESTIMATED)
- **Why stopped:** Study is now terminated due to technical difficulties with administration of study drug in this patient population with this schedule
- **Last updated:** 2009-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00497679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00497679, "AZD1152 in Patients With Advanced Solid Malignancies-Study 3". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00497679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*